<?php
   $title = "The Beyond 1 Million Genomes (B1MG) Maturity Level Model (MLM)";
   $description = "Publications, media and deliverables from the B1MG project.";
   $section = "resources";
   $page = "maturit-level-mopdel";
   include $_SERVER['DOCUMENT_ROOT']."/includes/header.inc";
?>
<section class="hero is-primary">
    <div class="hero-body py-5">
        <div class="container">
            <h1 class="title">
                Maturity Level Model (MLM)
            </h1>
        </div>
    </div>
</section>
<section class="section pt-55">
    <div class="container content has-text-grey-darker">
    <p>The <strong>B1MG Maturity Level Model (MLM)</strong> aims to promote and facilitate the adoption of genomics
            by healthcare
            systems for making personalised medicine accessible to citizens and patients across Europe.</p>
        <p>Experts from the B1MG project developed the MLM framework to enable all interested countries to self evaluate
            the level of maturity of national genomic medicine practices following a common matrix.</p>
        
        <div class="tabs is-boxed is-medium mb-0">
            <ul class="has-text-weight-bold mt-0">
                <li class="is-active"><a data-panel="mlm" class="tab">B1MG MLM</a></li>
                <li><a data-panel="glossary" class="tab">Glossary</a></li>
            </ul>
        </div> 
        <div data-panel="mlm" class="tab-panel">
            <button class="accordion single-line">I. Governance and strategy</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%;">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Governance</td>
                            <td>Country/region has a dedicated governance for genomics in healthcare.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No dedicated governance for genomics in healthcare.</li>
                                    <li>Elements of governance exist but they are not fully functional.</li>
                                    <li>Scope of governance for genomics has been defined but elements are still under
                                        development.</li>
                                    <li>There is a governance body that is fully operating, led centrally, and
                                        activities
                                        are monitored based on a work plan.</li>
                                    <li>Governance body is institutionalised, recognised as the lead for genomics in
                                        healthcare, and is open to novel developments and supportive of international
                                        cooperation.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Priority</td>
                            <td>Genomics in healthcare is established as a priority at national/regional level.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Genomics in healthcare is not included in national/regional health plans.</li>
                                    <li>Inclusion of genomics in healthcare in relevant national/regional health plans
                                        is
                                        under discussion.</li>
                                    <li>Genomics in healthcare is included in relevant national/regional health plans.
                                    </li>
                                    <li>Genomics in healthcare is implemented as part of national/regional health and
                                        other
                                        relevant plans (e.g. education, research).</li>
                                    <li>Genomics in healthcare is implemented in health and other relevant plans, and is
                                        periodically evaluated for optimisation, taking into account novel developments
                                        at
                                        the international level.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Strategy</td>
                            <td>There is a national/regional strategy for genomics in healthcare with a costed
                                implementation plan.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No genomics in healthcare strategy with costed implementation plan.</li>
                                    <li>A strategy for genomics in healthcare with costed implementation plan under
                                        discussion.</li>
                                    <li>A costed implementation plan for genomics in healthcare is developed and
                                        approved.
                                    </li>
                                    <li>The national/regional strategy for genomics in healthcare is under
                                        implementation.
                                    </li>
                                    <li>The national/regional strategy for genomics in healthcare is implemented, with
                                        monitoring and long term resources and aligned with European and international
                                        strategies.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">II. Investment and economic model</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Investment</td>
                            <td>There is an investment plan at the national and/or regional levels for genomics in
                                healthcare, with public or mixed public-private funding models.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>There is no established investment plan at the national or regional level for
                                        genomics in healthcare.</li>
                                    <li>An investment plan for genomics in healthcare at the national and/or regional
                                        levels
                                        is under development.</li>
                                    <li>There is a national and/or regional investment plan for genomics in healthcare
                                        that
                                        is mostly dedicated to setting up infrastructure</li>
                                    <li>There is a national and/or regional investment plan for the regular operational
                                        costs of genomics in healthcare (for specific tests e.g. for rare diseases
                                        diagnostics or specific cancer treatments).</li>
                                    <li>There is a national and/or regional investment plan for genomics in healthcare
                                        that
                                        incorporates innovation according to opportunities and international
                                        developments.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Access and reimbursement</td>
                            <td>There is a framework for reimbursement or no-cost access plans for genomic tests, at the
                                national or regional levels.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No framework for reimbursement or no-cost access plans for genomic tests.</li>
                                    <li>A framework for reimbursement or no-cost access plans for specific genomic tests
                                        is
                                        under development.</li>
                                    <li>A reimbursement framework or no-cost access plans for specific genomic tests are
                                        developed, approved and operationalised, with disease or patient-specific
                                        models.
                                    </li>
                                    <li>A reimbursement framework or no-cost access plans for specific genomic tests are
                                        fully implemented in national and/or regional healthcare systems.</li>
                                    <li>A reimbursement framework or no-cost access plans for specific genomic tests are
                                        fully implemented, periodically evaluated and optimised, with plan for adoption
                                        of
                                        novel tools and technologies.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold is-borderless" rowspan="3">Health economics</td>
                            <td>There is a HTA framework to assess genomic tests in healthcare.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No HTA framework for genomic testing.</li>
                                    <li>HTA framework for genomic testing is under development.</li>
                                    <li>HTA framework for genomic testing is developed and approved.</li>
                                    <li>HTA framework for genomic testing is implemented in healthcare system.</li>
                                    <li>HTA framework is implemented, periodically evaluated and optimised, with plan
                                        for
                                        adoption of novel tools and technologies.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There is a framework for cost-effectiveness assessment of genomic tests.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>There is no framework for cost-effectiveness assessment of genomic tests.</li>
                                    <li>A framework for cost-effectiveness assessment of genomic tests is under
                                        development.
                                    </li>
                                    <li>A framework for cost-effectiveness assessment of specific genomic tests in the
                                        healthcare context are under implementation as pilots.</li>
                                    <li>A framework for cost-effectiveness assessment of specific genomic tests is
                                        implemented in healthcare systems at the national and/or regional levels.</li>
                                    <li>A framework for cost-effectiveness assessment of genomic tests is implemented,
                                        periodically evaluated and optimised, with plan for adoption of novel tools and
                                        technologies.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Societal benefits are considered in economic modelling for genomic medicine.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Societal benefits are not considered in economic models for genomics in
                                        healthcare.
                                    </li>
                                    <li>Societal benefits are quantified in economic models for genomics in healthcare.
                                    </li>
                                    <li>Societal benefits are integrated in economic models for specific genomic tests.
                                    </li>
                                    <li>Societal benefits are integrated in global genomics economic models for regional
                                        or
                                        national healthcare systems.</li>
                                    <li>Societal benefits are integrated in global genomics economic models for regional
                                        or
                                        national healthcare systems and optimised for novel tools and technologies.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">III. Ethics, legislation and policy</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="3">Data protection and privacy</td>
                            <td>There are norms to protect and ensure the lawful, fair and transparent processing of
                                personal data.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are norms protecting the confidentiality of patient genetic/genomic test results,
                                and
                                specifically clarifying where family members may have rights to access these results.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist</li>
                                    <li>Norms are implemented but insufficient in scope</li>
                                    <li>Norms are implemented but not yet consistently enforced</li>
                                    <li>Norms are implemented and consistently enforced</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are norms limiting genetic/genomic testing to legitimate purposes and preventing
                                mis-use (e.g. no employer/insurer discrimination).</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="2">Consent to genetic/genomic testing</td>
                            <td>There are norms to ensure appropriate consent is obtained and counselling is provided in
                                relation to genetic/genomic testing.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are special rules to ensure that vulnerable groups have access to genetic/genomic
                                testing, with counselling and appropriate protections to fully respect their rights and
                                avoid their exploitation.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Quality of patient care involving genetic/genomic testing
                            </td>
                            <td>There are norms ensuring the quality of genetic/genomic testing services (e.g.
                                professional
                                codes and self-regulatory bodies).</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="3">Health data sharing and reuse</td>
                            <td>There are norms addressing the accreditation, registration, supervision, secure storage,
                                and
                                responsible use (including exchange and sharing) of human biological samples.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There is a national strategy for promoting health research and innovation, and
                                associated
                                data protection rules allowing sharing and further processing of health/genetic data for
                                research or treating other patients.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are norms facilitating genomic data sharing by researchers and/or healthcare
                                providers, at the national and international levels.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold is-borderless" rowspan="2">Research ethics</td>
                            <td>There are norms and processes ensuring the ethical practice and scientific integrity of
                                genomic research.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Norms (e.g. legislation, policies, professional regulations, codes of conduct)
                                        do
                                        not exist.</li>
                                    <li>Norms are implemented but insufficient in scope.</li>
                                    <li>Norms are implemented but not yet consistently enforced.</li>
                                    <li>Norms are implemented and consistently enforced.</li>
                                    <li>Norms are implemented, enforced and fit-for-purpose.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There is a national (or regional if appropriate) research ethics committee or network to
                                effectively and efficiently oversee the conduct of multicentre genetic/genomic studies.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>A framework for national or regional research ethics committee to oversee
                                        multicentre genetic/genomic studies does not exist.</li>
                                    <li>A framework for national or regional research ethics committee to oversee
                                        multicentre genetic/genomic studies is under development.</li>
                                    <li>A framework for national or regional research ethics committee to oversee
                                        multicentre genetic/genomic studies exists, but is not consistently enforced.
                                    </li>
                                    <li>A framework for national or regional research ethics committee to oversee
                                        multicentre genetic/genomic studies is implemented and consistently enforced.
                                    </li>
                                    <li>A framework for national or regional research ethics committee to oversee
                                        multicentre genetic/genomic studies is implemented, enforced and
                                        fit-for-purpose.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">IV. Public awareness and acceptance</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Awareness</td>
                            <td>There are literacy programmes or campaigns on genomic medicine with monitored impact on
                                awareness.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No</li>
                                    <li>Literacy programmes or campaigns are available locally as a bottom up
                                        initiative, on
                                        particular topics.</li>
                                    <li>Strategy for literacy programmes or campaigns targeting specific audiences is
                                        defined, based on genomic literacy surveys, and under implementation.</li>
                                    <li>Strategy for literacy programmes or campaigns targeting specific audiences is
                                        defined, and widely implemented with dedicated funds.</li>
                                    <li>Strategy for literacy programmes or campaigns is widely implemented, with
                                        regular
                                        evaluation and monitoring of impact on awareness, update of topics to include
                                        innovation, and with dedicated funds.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Acceptance</td>
                            <td>Synergies with patient associations are well established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No</li>
                                    <li>Available locally as a bottom up initiative with specific associations.</li>
                                    <li>Strategy for engaging patient associations in genomic medicine issues is defined
                                        and
                                        under implementation.</li>
                                    <li>
                                    <li>Strategy for engaging patient associations in genomic medicine issues is widely
                                        implemented at national level, with dedicated funds.</li>
                                    </li>
                                    <li>Strategy for engaging patient associations in genomic medicine issues is widely
                                        implemented at national level, with dedicated funds, regular monitoring and
                                        updates
                                        to include innovation.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Communication to the general public</td>
                            <td>There is a communication strategy for genomic medicine.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No</li>
                                    <li>Available locally as a bottom up initiative with specific target audiences.</li>
                                    <li>A global strategy for communication with the public is under developmen.t</li>
                                    <li>A global strategy for communication with the public is widely implemented, with
                                        dedicated funds.</li>
                                    <li>A global strategy for communication with the public is widely implemented, with
                                        dedicated funds and regular monitoring, and includes tools for active
                                        involvement of
                                        the public in general, minorities and youth in particular.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">V. Workforce skills and organisation</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="3">Education</td>
                            <td>Genomics is integrated in general university curricula for medical doctors.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, training options under development.</li>
                                    <li>Training available, under implementation.</li>
                                    <li>Training available and widely implemented.</li>
                                    <li>Training curricula regularly updated to incorporate novel technologies and
                                        tools.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Genomics is integrated in general curricula for nurses.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, training options under development.</li>
                                    <li>Training available, under implementation.</li>
                                    <li>Training available and widely implemented.</li>
                                    <li>Training curricula regularly updated to incorporate novel technologies and
                                        tools.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Genomics is integrated in general curricula for pharmacists.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, training options under development.</li>
                                    <li>Training available, under implementation.</li>
                                    <li>Training available and widely implemented.</li>
                                    <li>Training curricula regularly updated to incorporate novel technologies and
                                        tools.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="3">Careers in genomic medicine</td>
                            <td>There are officially recognised professional titles and career paths for genomic
                                medicine.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No workforce strategy or policy that recognises genomic medicine professionals,
                                        and
                                        distribution of professionals is <i>ad hoc</i>.</li>
                                    <li>Strategy or policy for genomic medicine professionals is proposed and under
                                        review.
                                    </li>
                                    <li>Strategy or policy for genomic medicine professionals is approved and under
                                        implementation.</li>
                                    <li>Strategy or policy for genomic medicine professionals is implemented, with full
                                        recognition and acceptance of career paths.</li>
                                    <li>Professional titles and career paths for genomic medicine professionals are
                                        flexible
                                        and regularly updated to incorporate needs from novel technologies and tools.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are training programmes for genetic counselling.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, training options under development.</li>
                                    <li>Training graduates are available but not yet deployed.</li>
                                    <li>Training graduates are deployed, but essential personnel gaps remain.</li>
                                    <li>Sufficient numbers of training graduates are available to support evolving
                                        national/regional needs.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>There are life-long or continuing education programmes in genomic medicine for different
                                healthcare professionals.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, training options under development.</li>
                                    <li>Training available, under implementation.</li>
                                    <li>Training available and widely implemented.</li>
                                    <li>Training curricula regularly updated to incorporate novel technologies and
                                        tools.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Policy makers</td>
                            <td>There are programmes for policy makers and healthcare managers to raise awareness on
                                genomic
                                medicine and its implications for healthcare.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Needs assessed, gaps identified, programme options under development.</li>
                                    <li>Programmes available, under implementation.</li>
                                    <li>Fully functional implementation of programmes at national level.</li>
                                    <li>Programmes are implemented and periodically evaluated for inclusion of novel
                                        tools
                                        and technologies.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">VI. Clinical organisation, infrastructure and tools</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Information and Communications Technology (ICT) tools for
                                clinical decision</td>
                            <td>There are ICT tools supporting clinical interpretation of genomic results, clinical
                                decision-making and communication with the patient implemented in public hospitals and
                                clinics.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>ICT tools not available.</li>
                                    <li>ICT tools available in selected hospitals, frequently associated with research
                                        projects.</li>
                                    <li>ICT tools under wider implementation in healthcare systems following a strategy
                                        for
                                        genomic medicine.</li>
                                    <li>ICT tools implemented where needed as part of national/regional health systems
                                        strategies for genomic medicine.</li>
                                    <li>ICT tools implemented and periodically evaluated and optimised for novel tools
                                        and
                                        updates.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Multidisciplinary teams</td>
                            <td>Clinical teams for genomic medicine are multidisciplinary and include ICT, biomedical
                                and
                                psychology experts.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Not available.</li>
                                    <li>Teams are assembled in some hospitals as a bottom up initiative, but not all
                                        areas
                                        are covered or necessary tools are available.</li>
                                    <li>Guidelines for assembling multidisciplinary teams exist, and there are referral
                                        networks at regional/local level.</li>
                                    <li>Guidelines for assembling multidisciplinary teams and referral networks are
                                        implemented at regional/national level, aligned with a strategy for genomics in
                                        healthcare and with dedicated funding.</li>
                                    <li>Multidisciplinary teams are the norm for implementation of national genomics in
                                        medicine strategy and the guidelines for their assembly and operation, and
                                        referral
                                        networks, are reviewed and optimised periodically.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Uptake of novel tools and technologies for genomics</td>
                            <td>Adoption of novel technologies and software tools to support clinical decisions is
                                fit-for-purpose.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Novel technologies and tools are selected and implemented locally (e.g.
                                        hospital,
                                        laboratory).</li>
                                    <li>There are plans and processes for adoption of novel technologies and tools to
                                        support clinical decision making, but not widely implemented at
                                        regional/national
                                        levels.</li>
                                    <li>Plans and processes for adoption of novel technologies and tools to support
                                        clinical
                                        decision making are centralised at the regional/national levels, and aligned
                                        with a
                                        national strategy for genomics in healthcare.</li>
                                    <li>Plans and processes for adoption of novel technologies and tools to support
                                        clinical
                                        decision making are centralised at the regional/national levels, and aligned
                                        with a
                                        national strategy for genomics in healthcare and with international standards.
                                    </li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Synergies with research</td>
                            <td>There are processes established for the integration of the clinics with research
                                outcomes.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Implemented at a local level, depending on individual initiative.</li>
                                    <li>Implemented at local and regional level according to a local strategy for
                                        integrating stakeholders and partnerships.</li>
                                    <li>Implemented at national level with well established partnerships, support from
                                        public funds and dedicated budget.</li>
                                    <li>Implemented at national and international level with well established
                                        partnerships,
                                        periodically evaluated, support from public funds and dedicated budget.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Partnership with industry</td>
                            <td>There are effective partnerships with stakeholders from the industry sector.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No or <i>ad hoc</i>.</li>
                                    <li>Implemented at a local level, depending on individual initiative.</li>
                                    <li>Implemented at local and regional level according to a local strategy for
                                        integrating stakeholders and partnerships from the industry sector.</li>
                                    <li>Implemented at national level with well established partnerships, according to a
                                        national strategy for integration of industry stakeholders.</li>
                                    <li>Implemented with well established national and international partnerships,
                                        according
                                        to a national strategy for integration of industry stakeholders.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">VII. Clinical genomics guidelines and infrastructure</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Sequencing/ genotyping infrastructure</td>
                            <td>Genomic centres are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Genomic centres are local (e.g. hospital, laboratory).</li>
                                    <li>Genomic centres infrastructure networks are under development, to include common
                                        working guidelines and shared policies.</li>
                                    <li>Genomic centres infrastructure networks are implemented at the regional/national
                                        levels, and operate under common guidelines and policies.</li>
                                    <li>Genomic centres infrastructure networks are implemented at the regional/national
                                        levels, and operate under common guidelines and policies and aligned with global
                                        standards.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Sequencing guidelines</td>
                            <td>Guidelines for sequencing are defined.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for sequencing data generation are available locally(e.g. hospital,
                                        laboratory, project).</li>
                                    <li>Local level genomic sequence generation for clinical use is aligned with ISO
                                        laboratory accreditation/protocols.</li>
                                    <li>Genomic sequence generation is co-ordinated at regional/national level and
                                        aligned
                                        with ISO laboratory accreditation/protocols.</li>
                                    <li>Genomic sequence generation at regional/national level is governed in alignment
                                        with
                                        ISO accreditation/protocols, reviewed periodically, and in line with
                                        international
                                        standards.</li>

                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Primary bioinformatics analysis</td>
                            <td>Guidelines for genomic data analysis are defined.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for genomic data analysis are available at local/organisation level.
                                    </li>
                                    <li>Guidelines for genomic data analysis are available at the regional/national
                                        level.
                                    </li>
                                    <li>Standardised genomic analysis guidelines are implemented at national level and
                                        reviewed periodically.</li>
                                    <li>Standardised genomic analysis guidelines are implemented at national level,
                                        reviewed
                                        periodically and aligned with global standards.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Structure of sequence-associated metadata</td>
                            <td>Guidelines for sequence-metadata structure to support clinical interpretation are
                                established.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines to structure metadata to meet clinical use cases are defined locally
                                        (e.g. at the hospital, laboratory level).</li>
                                    <li>Guidelines to structure metadata to meet clinical use cases are defined
                                        regionally/nationally.</li>
                                    <li>Standardised guidelines to structure metadata to meet clinical use cases are
                                        implemented at the national level and are reviewed periodically.</li>
                                    <li>International guidelines to structure metadata to meet clinical use cases are
                                        followed, implemented at the national level and are reviewed periodically.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Clinical interpretation</td>
                            <td>Guidelines for clinical interpretation of genomic results are defined.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for clinical interpretation of genomic results are defined locally
                                        (e.g.
                                        at the hospital, laboratory level).</li>
                                    <li>Guidelines for clinical interpretation of genomic results are defined
                                        regionally/nationally (e.g. by national genetics societies).</li>
                                    <li>Guidelines for clinical interpretation of genomic results from internationally
                                        recognised bodies (e.g. ACMG, ClinGen) are implemented nationally.</li>
                                    <li>Guidelines for clinical interpretation of genomic results from internationally
                                        recognised bodies are implemented nationally, and there are interactions with
                                        these
                                        international bodies for guideline definition for specific diseases (e.g. ACMG,
                                        ClinGen).</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Clinical reporting</td>
                            <td>Guidelines for clinical reporting of genomic results are defined.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Consistent clinical reporting guidelines are developed at an organisational
                                        level.
                                    </li>
                                    <li>National best practices for clinical reporting are defined and monitored, but
                                        not
                                        consistently enforced.</li>
                                    <li>National best practices for clinical reporting are enforced and monitored.</li>
                                    <li>Guidelines for clinical reporting are enforced at the national levels, in
                                        alignment
                                        with international standards and regularly reviewed based on changes in
                                        technological, regulatory and ethical considerations.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
            <button class="accordion single-line">VIII. Data management, standards and infrastructure</button>
            <div class="accordion-panel">
                <div>
                    <table>
                        <tr>
                            <th class="is-size-5 percent-20">Subdomain</th>
                            <th class="is-size-5" style="width: 30%">Indicators</th>
                            <th class="is-size-5">Maturity levels</th>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Data security</td>
                            <td>Infrastructure and policies for data security are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Security policies and infrastructure are defined at the organisation level.</li>
                                    <li>Security policies and infrastructure are nationally defined but not sufficiently
                                        enforced.</li>
                                    <li>Security policies and infrastructure are established under national regulation
                                        and
                                        fully enforced.</li>
                                    <li>Security policies follow international best practices for data security and are
                                        regularly reviewed based on changes in technological, regulatory and ethical
                                        considerations.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Data discoverability (findable)</td>
                            <td>Guidelines for structuring metadata for datasets are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for structuring metadata for datasets are established at the local
                                        level.
                                    </li>
                                    <li>Guidelines for structuring metadata for datasets established at the local level
                                        are
                                        documented and implemented, and their usage is tracked.</li>
                                    <li>Guidelines for structuring metadata for datasets are established nationally.
                                    </li>
                                    <li>Guidelines for structuring metadata for datasets are established nationally, and
                                        there is national level interaction with the development and adoption of
                                        international standards for dataset metadata structure and labelling.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="2">Data access management (accessible)</td>
                            <td>Data access governance framework is established.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Data access governance is established locally (e.g. by department, institution).
                                    </li>
                                    <li>Scope of data access governance is defined nationally or regionally, with
                                        stakeholder consultation.</li>
                                    <li>Data access governance is led centrally, fully functional, and implementation is
                                        monitored based on a national or regional work plan.</li>
                                    <li>Data access governance structure is institutionalised, protected from
                                        interference
                                        or organisational changes, and open to novel developments.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Data sharing policies and data flows are established.
                            </td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Data access granting is fully manual, with individual agreements created with
                                        each
                                        request.</li>
                                    <li>Standardised local data sharing policies are established, with limited data
                                        flows
                                        managed electronically.</li>
                                    <li>Electronic systems are implemented to support data sharing policies and are
                                        adopted
                                        nationally.</li>
                                    <li>Application for data access is semi-automated and follows international
                                        standards
                                        and there is national representation on the continued development of these
                                        standards.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold" rowspan="4">Reception and interfaces (interoperable)</td>
                            <td>Guidelines for record level data structure are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for record structure for discovery are established at the local
                                        level.
                                    </li>
                                    <li>Guidelines for record structure for discovery are established at the local level
                                        and
                                        are documented, implemented and their usage is tracked.</li>
                                    <li>Guidelines for record structure for discovery are established nationally and are
                                        documented, implemented and their usage is tracked.</li>
                                    <li>Guidelines for record structure are established nationally and there are
                                        national
                                        level interactions for the development and adoption of international standards
                                        for
                                        dataset structure for discovery.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Guidelines for dataset structure are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Guidelines for dataset structure and access for discovery are established at the
                                        local level.</li>
                                    <li>Guidelines for dataset structure and access for discovery are established at the
                                        local level and are documented, implemented and their usage is tracked.</li>
                                    <li>Guidelines for record structure and access for discovery are established
                                        nationally
                                        and are documented, implemented and their usage is tracked.</li>
                                    <li>Guidelines for dataset structure and access for discovery are established
                                        nationally
                                        and there are national level interactions for the development and adoption of
                                        international standards.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Data sharing infrastructure is established using a federated model.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Data sharing infrastructure is set up locally (e.g. by department, institution).
                                    </li>
                                    <li>Data sharing infrastructure interoperates within the region.</li>
                                    <li>Data sharing infrastructure interoperates with infrastructures from other
                                        regions.
                                    </li>
                                    <li>Data sharing infrastructure interoperates with an international federation.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td>Services for data reception to support interoperability are established.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>Genomic data services accept unstructured data without quality control measures.
                                    </li>
                                    <li>Genomic data services have quality control measures and formats implemented
                                        locally
                                        (e.g. by department, institution).</li>
                                    <li>Genomic data services quality control measures and formats are implemented
                                        locally
                                        but all data received align with international standards.</li>
                                    <li>Genomic data services accept data only in formats agreed nationally/regionally
                                        and
                                        there is automatic quality control upon reception.</li>
                                    <li>All data received into genomic data services are automatically validated to
                                        ensure
                                        alignment with international standards.</li>
                                </ol>
                            </td>
                        </tr>
                        <tr>
                            <td class="has-text-weight-bold">Processing and analysis (reusable)</td>
                            <td>Computational and data infrastructure for medical reuse and secondary data analysis is
                                available.</td>
                            <td>
                                <ol class="mt-0">
                                    <li>No.</li>
                                    <li>Computational and data infrastructure is available to support local analysis of
                                        data.</li>
                                    <li>Computational and data infrastructure is available to support trans-regional
                                        analysis of data.</li>
                                    <li>Computational and data infrastructure is in place to support national analysis
                                        of
                                        data.</li>
                                    <li>Computational and data infrastructure supports national analysis of data and is
                                        aligned with and supports cross-border data analysis.</li>
                                </ol>
                            </td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>
        <div data-panel="glossary" class="tab-panel is-hidden">
            <p>The glossary includes definitions of the use and context of phrases and terminologies used in the MLM to
                avoid bias and personal interpretations.</p>
            <dl>
                <dt id="Acceptance">Acceptance</dt>
                <dd>Perceived usefulness of genomic medicine to patients. Recognition from citizens, patients and
                    patients' associations of a positive impact of the use of genomic medicine on patients levels of
                    satisfaction</dd>

                <dt id="API">API</dt>
                <dd>Application Programming Interface. A software intermediary that allows two applications to talk to
                    each other.</dd>

                <dt id="Awareness">Awareness</dt>
                <dd>Public's level of understanding about the importance and implications of genomic medicine.</dd>

                <dt>Centrally</dt>
                <dd>Based within a national or regional node.</dd>

                <dt id="Clinical interpretation of genomic results">Clinical interpretation of genomic results</dt>
                <dd>Translation of the technical output of a clinical genetic or genomic test into potentially
                    clinically actionable information.</dd>

                <dt id="Cost-effectiveness assessment">Cost-effectiveness assessment</dt>
                <dd>Cost-effectiveness analysis is a form of economic analysis that compares the relative costs and
                    outcomes of different courses of action.</dd>

                <dt id="Costed implementation plan">Costed implementation plan</dt>
                <dd>A multi-year roadmap that enables governments to prioritise interventions, engage stakeholders
                    around one strategy, forecast costs and mobilise resources to meet identified gaps, namely to
                    implement genomics in healthcare systems.

                </dd>
                <dt id="Data protection">Data protection</dt>
                <dd>Certainity that personal data is used fairly, lawfully and transparently  for specified, explicit
                    purposes  in a way that is adequate, relevant and limited to only what is necessary, accurate and,
                    where necessary, kept up-to-date, for no longer than is necessary, and handled in a way that ensures
                    appropriate security, including protection against unlawful or unauthorised processing, access,
                    loss, destruction or damage.</dd>

                <dt id="Data reuse">Data reuse</dt>
                <dd>Reuse, or secondary use, of health data for purposes other than the primary reason for which they
                    were originally saved. Other purposes may include scientific research, development and innovation
                    activities, teaching and statistics.</dd>

                <dt id="Data reception">Data reception</dt>
                <dd>Uniform processes (such as quality control and standardisation) to receive (download) or access
                    (through API) both data and metadata in a consistent way, enabling infrastructures to adhere to
                    global standards and principles for genotypic and phenotypic data. It includes logically describing
                    datasets to an extent that they can become actionable on the infrastructure, even if they are stored
                    nationally or locally. (Adapted from the 1+MG Scoping paper)</dd>

                <dt id="Dataset structure">Dataset structure</dt>
                <dd>The dataset is formatted in a standard way to support interoperability, i.e. via use of
                    international standards.</dd>

                <dt id="Dedicated Governance">Dedicated governance</dt>
                <dd>The process by which decisions are made and implemented. Governance is the process by which public
                    institutions conduct public affairs and manage public resources.</dd>

                <dt id="Economic model">Economic model</dt>
                <dd>A structured approach to help decision-makers choose between alternative ways of using resources, by
                    weighting the cost of an action against the benefits that it provides. It is frequently used to
                    anticipate the costs and benefits of new health care technologies, policies and regulations.</dd>

                <dt id="Federated model">Federated model</dt>
                <dd>A distributed network of repositories for sharing genomic information.</dd>
                <dt id="Further processing">Further processing</dt>
                <dd>The processing of personal data for a different purpose(s) than the initially collected.</dd>

                <dt id="Genetic data">Genetic data</dt>
                <dd>Personal data related to the inherited or acquired genetic characteristics of an individual, which
                    give unique information about his/her physiology or health, that result from an analysis of a
                    biological sample from the individual in question. [ref. Art. 4(13) GDPR]</dd>

                <dt id="Guidelines for clinical interpretation of genomic results">Guidelines for clinical
                    interpretation of genomic results</dt>
                <dd>Guidelines for translating the technical output of a genetic or genomic test into potentially
                    clinically actionable information.</dd>

                <dt id="Guidelines for clinical reporting of genomic results">Guidelines for clinical reporting of
                    genomic results</dt>
                <dd>Guidelines for reporting the actionable results of a genetic or genomic test to the attending
                    clinician and/or patient.</dd>

                <dt id="Health data">Health data</dt>
                <dd>Personal data related to the physical or mental health of an individual independent of its origin
                    (e.g. healthcare context, research, clinical trials, the data subject directly, smart devices).
                    [ref. Art. 4 GDPR]</dd>

                <dt id="HTA">HTA framework</dt>
                <dd>Health Technology Assessment framework. A multidisciplinary process that uses explicit methods to
                    determine the value of health technology at different points in its lifecycle to help
                    decision-makers make informed decisions.</dd>

                <dt id="ICT">ICT (clinical) tools</dt>
                <dd>Information and communication technology, such as electronic health records, telehealth or online
                    resources.</dd>

                <dt id="ISO">ISO</dt>
                <dd>The International Organisation for Standardisation</dd>

                <dt id="Locally">Locally</dt>
                <dd>Within a single institution, i.e. not beyond a lab, department or hospital.</dd>

                <dt id="Metadata">Metadata</dt>
                <dd>Data that provides information about other data. For example, the origin of the data, the processing
                    details or the sharing permissions.</dd>

                <dt id="Multidisciplinary teams">Multidisciplinary teams</dt>
                <dd>Teams comprised of individuals who span across different areas of expertise to cover all knowledge
                    areas required for genomic medicine.</dd>

                <dt id="No-cost access plan">No-cost access plan</dt>
                <dd>Detailed set of rules that determines rights, duties and procedures to benefit from access to
                    genomic tests at no cost</dd>

                <dt id="Norms">Norms</dt>
                <dd>A set of principles of right action binding upon group members and serving to guide, control or
                    regulate appropriate and acceptable behaviour. E.g. legislation, policies, professional regulations,
                    codes of conduct.</dd>

                <dt id="Personal data">Personal data</dt>
                <dd>Data related to a living individual, who is likely to be identified by the data directly or combined
                    with other data (e.g. through a pseudonym). [ref. Art. 4 GDPR]</dd>

                <dt id="Primary bioinformatics analysis">Primary bioinformatics analysis</dt>
                <dd>The initial analysis that turns the machine output of genomic sequencing into genomic information
                    for clinical/research interpretation or other contexts.</dd>

                <dt id="Reception and interfaces">Reception and interfaces</dt>
                <dd>This consists of two areas.<br>
                    <strong>(1) Reception</strong>. Uniform processes (such as quality control and standardisation) to
                    receive (download) or access (through API) both data and metadata in a consistent way, enabling
                    infrastructures to adhere to global standards and principles for genotypic and phenotypic data. It
                    includes logically describing datasets to the extent that they can become actionable on the
                    infrastructure, even if they are stored nationally or locally. <br>
                    <strong>(2) Interfaces</strong>. Organisations offer interfaces (APIs) following international
                    standards that form the technically interoperable infrastructure backbone.<br>[Adapted from the 1+MG
                    Scoping paper]
                </dd>

                <dt id="Record">Record</dt>
                <dd>A dataset record is a collection of fields of information about the same person, item or object in a
                    database. It can be thought of as a row of information within a database table.</dd>

                <dt id="Secondary analysis">Secondary data analysis</dt>
                <dd>The use of existing data, collected for a prior study, to pursue a research interest that is
                    different to that of the original work. [ref: <a
                        href="https://sru.soc.surrey.ac.uk/SRU22/">https://sru.soc.surrey.ac.uk/SRU22.html</a>]</dd>

                <dt id="Sequence-associated metadata">Sequence-associated metadata</dt>
                <dd>Data that provides information about other data, specifically about genomic-sequence data.</dd>

                <dt id="Societal benefits">Societal benefits</dt>
                <dd>Any advantages, gains or improvements as a result of employing a genomic approach to a group of
                    people (e.g. patients, citizens).</dd>

                <dt id="Structured dataset metadata">Structured dataset metadata</dt>
                <dd>Metadata (data that provides information about other data) for datasets that supports data
                    discoverability using international standards.</dd>

                <dt>Vulnerable groups</dt>
                <dd>Vulnerable groups of population include children, adults with diminished capacities, the elderly,
                    racial or ethnic minorities, the socioeconomically disadvantaged, underinsured or those with certain
                    medical conditions who are at risk for unequal healthcare access, outcomes and exploitation.</dd>
            </dl>
        </div>
        <h2 class="is-size-3 mb-2">See also:</h2>
        <ul class="mt-0">
            <li><a href="/about/how-organised">How the project is organised</a></li>
            <li><a href="/about/how-organised">Work Packages</a></li>
            <li><a href="/about/objectives">Objectives and key results</a></li>
        </ul>
    </div>
</section>
<?php
   include $_SERVER['DOCUMENT_ROOT']."/includes/footer.inc";
?>
